Genomtec S.A. (WSE:GMT)
Poland flag Poland · Delayed Price · Currency is PLN
3.840
-0.060 (-1.54%)
Aug 14, 2026, 5:00 PM CET

Genomtec Financials Overview

Millions PLN. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.030.02000.040.22
Revenue Growth
400.00%1800.00%0%-97.50%-81.73%995.00%
Gross Profit
-8.1-7.18-4.31-0.79-3.23-5.16
Operating Income
-8.59-9.55-11.06-8.82-11.49-7
Net Income
-9.21-10.22-11.21-9.01-11.93-7.12
Earnings Per Share
-0.61-0.68-0.84-0.74-1.27-0.87
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2.610.956.74.174.141.38
Total Debt
1.861.262.741.992.291.75
Net Cash (Debt)
0.74-0.313.962.181.85-0.36
Net Cash Growth
-93.39%-81.61%17.83%--
Net Cash Per Share
0.05-0.020.300.180.20-0.04

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-9.34-10.86-6.72-7.95-3.6-5.5
Capital Expenditures
-0.09-0.09-0.06-3.53-4.33-0.21
Free Cash Flow
-9.43-10.95-6.78-11.48-7.93-5.71
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Margin
-28646.67%-50257.90%-1106400.00%-881500.00%-28730.00%-3194.06%
Pretax Margin
-30976.67%-54063.16%-1118800.00%-903100.00%-29705.00%-3246.58%
Profit Margin
-30710.00%-53800.00%-1120800.00%-901300.00%-29820.00%-3248.86%
FCF Margin
-31440.00%-57626.32%-677500.00%-1147900.00%-19822.50%-2608.68%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1928.273012.93104731.12132998.062720.29348.32